PRÄEKLAMPSIE

European patent · EP3960184 · In force

Register entry

Publication number
EP3960184
Application number
EP21191117
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 16, 2016
Published
Mar 2, 2022
Granted
Sep 11, 2024
Protection ends at the latest
Mar 15, 2036
Next annual fee due
Mar 31, 2027
IPC classes
A61K 31/7105 (2006.01)
G01N 33/50 (2006.01)
A61P 9/12 (2006.01)
A61P 9/00 (2006.01)
Priority
GB 201504772 20.03.2015
Divided from
EP16713006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Jul 23, 2025

    Change

    Published in Swissreg on 23.07.2025

  3. Apr 3, 2025

    Change

    Published in Swissreg on 03.04.2025

  4. Oct 31, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 31.10.2024

  5. Sep 11, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.09.2024

Parties

Holder

MirZyme Therapeutics Limited

Faraday Wharf Innovation Birmingham Campus Holt Street, Birmingham, West Midlands B7 4BB, GB

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

AHMED, Asif

Birmingham, B4 7ET, GB

CAI, Meng

Birmingham, B4 7ET, GB

WANG, Keqing

Birmingham, B4 7ET, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.